These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 158350)

  • 1. [Electrocardiographic evolution of severe medically treated hypertension].
    Blancher JF; Ben-Mais H; Simon A; Aboras N; Kheder A; Safar M
    Arch Mal Coeur Vaiss; 1979 Mar; 72(3):296-300. PubMed ID: 158350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Medically treated severe arterial hypertension. Long term course].
    Safar M; Simon A; Maiz B; Weiss Y; Milliez P
    Nouv Presse Med; 1975 May; 4(19):1403-6. PubMed ID: 807910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effectiveness of long-term treatment of patients with hypertension].
    Gurgenian SV; Mikaelian ES; Pogosian SA; Babaian AS; Arutiunian EA
    Ter Arkh; 1988; 60(2):89-92. PubMed ID: 2966992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The development of coronary insufficiency during prolonged treatment of essential hypertension.
    Kalnins UV; Skarda IJ; Liepinja DJ; Vitols AV
    Cor Vasa; 1990; 32(1):64-71. PubMed ID: 2140319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Complication and prognosis in essential hypertension].
    Hiwada K; Imamura Y
    Nihon Rinsho; 1992 May; 50 Suppl():238-45. PubMed ID: 1387423
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cardiac hypertrophy in hypertension].
    Yamasaki H; Kaku T; Ueda K
    Nihon Rinsho; 1992 May; 50 Suppl():400-5. PubMed ID: 1387425
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cardiac diseases complicated with hypertension].
    Yoshitomi Y; Abe H
    Nihon Rinsho; 1992 Apr; 50 Suppl():557-63. PubMed ID: 1386123
    [No Abstract]   [Full Text] [Related]  

  • 8. Differential effects of antihypertensive agents on electrocardiographic voltage: results from the Appropriate Blood Pressure Control in Diabetes (ABCD) trial.
    Havranek EP; Esler A; Estacio RO; Mehler PS; Schrier RW;
    Am Heart J; 2003 Jun; 145(6):993-8. PubMed ID: 12796754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of antihypertensive therapy on left ventricular hypertrophy in essential hypertension.
    Frohlich ED
    Adv Nephrol Necker Hosp; 1990; 19():87-100. PubMed ID: 1967894
    [No Abstract]   [Full Text] [Related]  

  • 10. Stroke and coronary heart disease in treated hypertension -- a prospective cohort study over three decades.
    Almgren T; Persson B; Wilhelmsen L; Rosengren A; Andersson OK
    J Intern Med; 2005 Jun; 257(6):496-502. PubMed ID: 15910553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular structural changes in hypertension: possible regression during long-term antihypertensive treatment.
    Novo S; Abrignani MG; Corda M; Strano A
    Eur Heart J; 1991 Dec; 12 Suppl G():47-52. PubMed ID: 1839619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regression of cardiac hypertrophy and night-time blood pressure reduction.
    Muiesan ML; Rizzoni D; Zulli R; Calebich S; Porteri E; Agabiti-Rosei E
    J Hypertens Suppl; 1993 Dec; 11(5):S300-1. PubMed ID: 8158395
    [No Abstract]   [Full Text] [Related]  

  • 13. Antihypertensive therapy and coronary prevention.
    Klein WW
    J Cardiovasc Pharmacol; 1990; 16 Suppl 6():S23-7. PubMed ID: 1707111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent ventricular repolarization markers in resistant hypertension: are they different from the traditional QT interval?
    Salles GF; Cardoso CR; Leocadio SM; Muxfeldt ES
    Am J Hypertens; 2008 Jan; 21(1):47-53. PubMed ID: 18091743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE).
    Okin PM; Oikarinen L; Viitasalo M; Toivonen L; Kjeldsen SE; Nieminen MS; Edelman JM; Dahlöf B; Devereux RB;
    Circulation; 2009 Apr; 119(14):1883-91. PubMed ID: 19332468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management of severe hypertension in France in 1999 and 2000: intermediate results of a health insurance intervention program].
    Tilly B; Guilhot J; Salanave B; Fender P; Allemand H
    Arch Mal Coeur Vaiss; 2002; 95(7-8):687-94. PubMed ID: 12365081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal management of hypertensive patients with LVH and dyslipidaemia.
    Plouin PF
    Int J Clin Pract Suppl; 1998 Nov; 98():9-12. PubMed ID: 10344025
    [No Abstract]   [Full Text] [Related]  

  • 18. [Heart of the hypertonic patient. Prognosis, therapeutic guidelines, appraisal].
    Anschütz F
    Fortschr Med; 1973 Jan; 91(1):8-11. PubMed ID: 4699342
    [No Abstract]   [Full Text] [Related]  

  • 19. [Methods for studying vasodilator agents in arterial hypertension].
    Laurent S; Asmar R; Pannier B; London G; Safar M
    Arch Mal Coeur Vaiss; 1990 Mar; 83 Spec No 2():69-73. PubMed ID: 2140502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of antihypertensive drug treatment on the incidence of cardiovascular morbidity and mortality in mild arterial hypertension].
    Tomov I
    Vutr Boles; 1985; 24(6):39-47. PubMed ID: 3913145
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.